Using a mouse model, scientists have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD). This discovery could lead to the development of drugs based on glycans — biological sugar molecules — for the treatment of diseases such as COPD, which is the fourth leading cause of death worldwide. …
Using a mouse model, scientists have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD). This discovery could lead to the development of drugs based on glycans — biological sugar molecules — for the treatment of diseases such as COPD, which is the fourth leading cause of death worldwide. …